Live Feed

Purchase price of US$73 per share in cash represents an enterprise value of US$11.3 billion (EUR 9.9 billion)Proposed acquisition expected to be immediately accretive to sales growth and EBITDA pre margin post-closing, and EPS pre accretive by year 3 after closingU.S.-based Bio-Techne to bring portfolio with industry-leading multi-omics offering, analytical technologies and integrated workflow solutions across the scientific journeyWould deliver on growth agenda of Merck KGaA, Darmstadt, Germany, by expanding presence in high-growth, next-generation life sciences markets and further strengthening the position as a leader along the full life science value chainWould add complementary strength

4 - ORIX CORP (0001070304) (Issuer)

3 - JBDI Holdings Ltd (0001964314) (Issuer)

Solid Execution Delivers Sales Growth, EPS Improvement and Strong Cash Flow Delivered Net Sales of $1.2B, an Increase of 2% Compared to the Prior YearDelivered Operating Profit of $193M, Up 38% Compared to the Prior Year; Grew Adjusted Operating Profit to $224M, Up 1% Compared to the Prior YearDelivered Diluted EPS of $4.56, Up 46% Compared to the Prior Year; Grew Adjusted Diluted EPS to $5.31, Up 4% Compared to the Prior Year ATLANTA, June 25, 2026 (GLOBE NEWSWIRE) -- Acuity Inc. (NYSE:AYI), ("Acuity"), a market-leading industrial technology company, delivered net sales of $1.2 billion in the third quarter, ended May 31, 2026, an increase of $19.4 million, or 1.6 percent, compared to t

Extends capabilities in attractive, high-growth medical segments Accelerates portfolio mix shift and path to >20% EBITDA margin target Expected to deliver ~$55 million in run-rate synergies H.B. Fuller Company ("H.B. Fuller" or "the Company") (NYSE:FUL), the world’s largest pureplay adhesives company, today announced it has made a recommended cash offer to acquire Advanced Medical Solutions Group plc ("AMS") (LSE:AMS). "This transaction is a rare opportunity to advance the evolution of our portfolio." said Celeste Mastin, President and CEO of H.B. Fuller. "We have long been clear that medical is a core strategic growth market for H.B. Fuller given its durable demand trends, high reg

New York, United States, June 25, 2026 (GLOBE NEWSWIRE) -- S&P Global Ratings has upgraded ratings on several subsidiaries of Freedom Holding Corp., a Nasdaq-listed international investment and technology group. The ratings on Freedom Finance JSC, Freedom Finance Europe Ltd., Freedom Finance Global PLC, and Freedom Bank Kazakhstan JSC were raised to "BB-" with stable outlooks. S&P also upgraded the long-term Kazakhstan national scale ratings on Freedom Finance JSC and Freedom Bank Kazakhstan JSC to "kzA-." Earlier, the agency affirmed Kazakhstan’s sovereign credit ratings at "kzAAA" on the national scale and "BBB-" with a positive outlook. Freedom Holding Corp.’s rating remained at "B-" w

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, June 25, 2026 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today reported its Q1 2026 financial results and provided a corporate update. "Our spin-out, Neurosterix, made great progress during the quarter and are on track to complete the Phase 1 study with NTX-253, an M4 positive allosteric modulator with potential in schizophrenia, in July," said Tim Dyer, CEO of Addex. "We look forward to seeing the data from the study when available later in the summer." Operating Highlights:

4 - Hinge Health, Inc. (0001673743) (Issuer)

4 - Hinge Health, Inc. (0001673743) (Issuer)

4 - Reservoir Media, Inc. (0001824403) (Issuer)

4 - DOMO, INC. (0001505952) (Issuer)

4 - Reservoir Media, Inc. (0001824403) (Issuer)

4 - Fortress Biotech, Inc. (0001429260) (Issuer)

4 - Reservoir Media, Inc. (0001824403) (Issuer)

4 - DOMO, INC. (0001505952) (Issuer)

4 - Reservoir Media, Inc. (0001824403) (Issuer)

4 - DOMO, INC. (0001505952) (Issuer)

4 - HELIOS TECHNOLOGIES, INC. (0001024795) (Issuer)

4 - HECLA MINING CO/DE/ (0000719413) (Issuer)

4 - COSTAR GROUP, INC. (0001057352) (Issuer)